Infixion Bioscience, Inc. - Company OverviewThe mission of Infixion Bioscience, Inc. ("InfixionBio") is to discover and develop therapeutics that radically improve the lives of people with Neurofibromatosis Type 1 (NF1). Our strategy is to exploit specific attributes of the NF1 genetic condition in ways not yet attempted by the NF1 research community, and to develop a targeted drug therapy that will prevent and reduce the full range of NF1 disease symptoms. InfixionBio has built a very solid scientific advisory board and research plan, and is currently fundraising to execute its proof of concept strategy.